Attitudes and intentions to receive medical and surgical abortions among women seeking pregnancy termination


Principal Investigator: Dr. Brian Fitzsimmons

Primary Contact: Nicole Prestley, Research Manager, 604-875-2424 ext 4956, 

About the study: Health Canada has recently approved Mifegymiso, a medication which is used around the world for medical termination of pregnancy. In order to understand how the use of this medication will impact Canadian women, WHRI is leading a study to learn how women feel about this method and whether or not they are interested in its use.

Why is this research important? Medical abortion has the potential to increase access to abortion services for women who live in rural and remote locations across the province. Additionally, as the CARE program is one of the first sites in Canada to offer this option, this research will help inform other Canadian sites that may also choose to provide this method.

Study status: Recruiting

Who can participated? Women who are seeking pregnancy termination at the CARE program are invited to participate.

Co-Investigators: Dr. Gina Ogilvie, Dr. Heather Armstrong, Caitlin Johnston, Nicole Prestley